UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:UHS • US9139031002

206.46 USD
-0.52 (-0.25%)
At close: Feb 4, 2026
206.46 USD
0 (0%)
After Hours: 2/4/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, UHS scores 6 out of 10 in our fundamental rating. UHS was compared to 102 industry peers in the Health Care Providers & Services industry. UHS has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on UHS. These ratings could make UHS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • UHS had positive earnings in the past year.
  • In the past year UHS had a positive cash flow from operations.
  • In the past 5 years UHS has always been profitable.
  • In the past 5 years UHS always reported a positive cash flow from operatings.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • UHS has a Return On Assets of 8.96%. This is amongst the best in the industry. UHS outperforms 91.18% of its industry peers.
  • UHS has a Return On Equity of 19.18%. This is amongst the best in the industry. UHS outperforms 87.25% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.33%, UHS belongs to the top of the industry, outperforming 87.25% of the companies in the same industry.
  • UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.16%.
  • The last Return On Invested Capital (12.33%) for UHS is above the 3 year average (8.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROIC 12.33%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of UHS (8.09%) is better than 88.24% of its industry peers.
  • UHS's Profit Margin has been stable in the last couple of years.
  • UHS has a better Operating Margin (11.47%) than 81.37% of its industry peers.
  • In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.09%
GM N/A
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

  • UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • UHS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UHS has less shares outstanding
  • The debt/assets ratio for UHS has been reduced compared to a year ago.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • An Altman-Z score of 3.13 indicates that UHS is not in any danger for bankruptcy at the moment.
  • UHS has a Altman-Z score of 3.13. This is in the better half of the industry: UHS outperforms 64.71% of its industry peers.
  • UHS has a debt to FCF ratio of 4.84. This is a neutral value as UHS would need 4.84 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.84, UHS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.55, UHS is doing good in the industry, outperforming 60.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Altman-Z 3.13
ROIC/WACC1.5
WACC8.22%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that UHS should not have too much problems paying its short term obligations.
  • UHS's Current ratio of 1.03 is on the low side compared to the rest of the industry. UHS is outperformed by 70.59% of its industry peers.
  • A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.96, UHS is doing worse than 67.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.96
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.07% over the past year.
  • UHS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
  • UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
  • UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%

3.2 Future

  • UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.53% yearly.
  • The Revenue is expected to grow by 4.90% on average over the next years.
EPS Next Y32.21%
EPS Next 2Y19.64%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue Next Year10.55%
Revenue Next 2Y7.72%
Revenue Next 3Y6.88%
Revenue Next 5Y4.9%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

8

4. Valuation

4.1 Price/Earnings Ratio

  • UHS is valuated reasonably with a Price/Earnings ratio of 9.93.
  • Based on the Price/Earnings ratio, UHS is valued cheaper than 92.16% of the companies in the same industry.
  • UHS is valuated cheaply when we compare the Price/Earnings ratio to 28.25, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 8.67, the valuation of UHS can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 94.12% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, UHS is valued rather cheaply.
Industry RankSector Rank
PE 9.93
Fwd PE 8.67
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 87.25% of the companies in the same industry.
  • UHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UHS is cheaper than 78.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 6.86
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UHS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as UHS's earnings are expected to grow with 16.81% in the coming years.
PEG (NY)0.31
PEG (5Y)0.92
EPS Next 2Y19.64%
EPS Next 3Y16.81%

6

5. Dividend

5.1 Amount

  • UHS has a yearly dividend return of 0.40%, which is pretty low.
  • UHS's Dividend Yield is rather good when compared to the industry average which is at 0.47. UHS pays more dividend than 80.39% of the companies in the same industry.
  • With a Dividend Yield of 0.40, UHS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

  • The dividend of UHS is nicely growing with an annual growth rate of 6.27%!
  • UHS has paid a dividend for at least 10 years, which is a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • UHS pays out 3.78% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y19.64%
EPS Next 3Y16.81%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (2/4/2026, 8:04:00 PM)

After market: 206.46 0 (0%)

206.46

-0.52 (-0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27
Earnings (Next)02-24
Inst Owners98.09%
Inst Owner Change-1.39%
Ins Owners5.68%
Ins Owner Change16.62%
Market Cap12.90B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts71.54
Price Target254.5 (23.27%)
Short Float %3.84%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)-0.13%
PT rev (3m)9.83%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)3.84%
EPS NY rev (1m)0%
EPS NY rev (3m)5.58%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 9.93
Fwd PE 8.67
P/S 0.76
P/FCF 13.32
P/OCF 6.62
P/B 1.8
P/tB 4.06
EV/EBITDA 6.86
EPS(TTM)20.8
EY10.07%
EPS(NY)23.82
Fwd EY11.54%
FCF(TTM)15.5
FCFY7.51%
OCF(TTM)31.18
OCFY15.1%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)0.31
PEG (5Y)0.92
Graham Number231.74
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROCE 16%
ROIC 12.33%
ROICexc 12.44%
ROICexgc 18.59%
OM 11.47%
PM (TTM) 8.09%
GM N/A
FCFM 5.7%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Debt/EBITDA 1.55
Cap/Depr 162.72%
Cap/Sales 5.77%
Interest Coverage 15.36
Cash Conversion 76.35%
Profit Quality 70.41%
Current Ratio 1.03
Quick Ratio 0.96
Altman-Z 3.13
F-Score8
WACC8.22%
ROIC/WACC1.5
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y32.21%
EPS Next 2Y19.64%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.55%
Revenue Next 2Y7.72%
Revenue Next 3Y6.88%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year60.86%
EBIT Next 3Y20.8%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%

UNIVERSAL HEALTH SERVICES-B / UHS FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 6 / 10 and the dividend payout ratio is 3.78%.